Access Statistics for Toshiaki Iizuka

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems 0 0 0 55 0 2 16 62
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 0 0 0 10 0 1 16 53
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 0 0 0 17 1 5 13 57
Drug Advertising and Health Habit 0 0 0 70 0 2 8 423
False Alarm? Estimating the Marginal Value of Health Signals 0 0 0 49 1 4 16 74
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 0 27 1 7 16 70
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 0 18 1 6 28 131
Is Zero a Special Price? Evidence from Child Healthcare 0 0 3 36 1 3 21 116
Long-term Care in Japan 0 2 3 23 3 18 36 66
Promoting Innovation in Small Markets: Evidence from the market for rare and intractable diseases 0 0 0 24 0 2 7 46
Robots and Labor in Nursing Homes 0 0 1 39 0 6 23 47
Robots and Labor in the Service Sector: Evidence from Nursing Homes 0 0 0 60 0 3 14 136
Total Working Papers 0 2 7 428 8 59 214 1,281


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An Empirical Analysis of Planned Obsolescence 0 1 2 75 1 7 23 270
Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems 0 0 0 1 1 1 18 42
Asymmetric Demand Response When Prices Increase and Decrease: The Case of Child Health Care 1 1 3 8 4 9 20 111
Cartel sustainability in retail markets: Evidence from a health service sector 0 0 0 19 1 5 18 133
Comment on “How does the Price Regulation Policy Impact on Patient–Nurse Ratios and the Length of Hospital Stays in Japanese Hospitals?” 0 0 0 1 0 3 11 31
Comment on “Sustainable Health Financing for COVID‐19 Preparedness and Response in Asia and the Pacific” 0 0 0 5 0 2 5 13
DIRECT TO CONSUMER ADVERTISING AND PRESCRIPTION CHOICE 0 0 1 79 0 1 5 240
DURABLE GOODS PRICE CYCLES: THEORY AND EVIDENCE FROM THE TEXTBOOK MARKET 0 0 0 9 0 4 11 75
Does Higher Malpractice Pressure Deter Medical Errors? 0 0 1 36 0 3 9 148
Effect of age-based left-digit bias on stroke diagnosis: Regression discontinuity design 0 1 1 2 1 6 14 20
Experts' agency problems: evidence from the prescription drug market in Japan 0 0 0 34 1 6 16 148
False alarm? Estimating the marginal value of health signals 0 0 0 6 1 10 28 85
GENERIC ENTRY IN A REGULATED PHARMACEUTICAL MARKET* 0 0 0 34 1 1 6 124
Is Zero a Special Price? Evidence from Child Health Care 0 0 2 13 3 7 26 62
Patient cost sharing and medical expenditures for the Elderly 0 1 3 26 1 3 18 137
Physician Agency and Adoption of Generic Pharmaceuticals 0 1 5 65 0 2 16 295
Promoting innovation in small markets: Evidence from the market for rare and intractable diseases 0 0 0 3 1 4 11 40
Robots and labor in nursing homes 0 2 2 2 5 18 55 71
The Effect of Prescription Drug Advertising on Doctor Visits 0 1 3 83 1 6 21 339
The Impact of Physician Supply on the Healthcare System: Evidence from Japan's New Residency Program 0 0 0 12 1 3 23 59
The generic drug market in Japan: will it finally take off? 0 0 0 32 0 4 14 108
What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs? 0 0 1 119 1 5 10 439
Total Journal Articles 1 8 24 664 24 110 378 2,990


Statistics updated 2026-06-04